Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
(2021).
The Emerging Role of Bone Markers in Diagnosis and Risk Stratification of Patients With Coronary Artery Disease..
Angiology. 70(8), 690-700.
(2019). New therapeutic targets for osteoporosis..
Maturitas. 120, 1-6.
(2019). The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited..
Seizure. 48, 36-43.
(2017). Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management..
J Clin Endocrinol Metab. 102(10), 3621-3634.
(2017). Heterotopic mesenteric ossification of ileostomy - "intraabdominal myositis ossificans"..
Rom J Morphol Embryol. 57(1), 277-81.
(2016). Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation..
Rheumatology (Oxford). 54(5), 908-14.
(2015). Multifocal septic osteomyelitis mimicking skeletal metastatic disease in a patient with prostate cancer..
Hell J Nucl Med. 18(1), 77-8.
(2015). Discordance between MRI and bone scan findings in a child with acute complicated osteomyelitis: scintigraphic features that contribute to the early diagnosis..
Rev Esp Med Nucl Imagen Mol. 33(2), 106-8.
(2014). Efficiency of different decalcification protocols for nasal osseous structures in a rat experimental model of allergic rhinitis, and their effects on epithelial histology: an attempt at standardization..
Exp Toxicol Pathol. 66(9-10), 469-75.
(2014). Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?.
Curr Med Res Opin. 30(6), 1177-8.
(2014). Skeletal tissue engineering using mesenchymal or embryonic stem cells: clinical and experimental data..
Expert Opin Biol Ther. 14(11), 1611-39.
(2014). Biologic therapies and systemic bone loss in rheumatoid arthritis..
Autoimmun Rev. 12(10), 958-66.
(2013). Effect of non-steroidal anti-inflammatory drugs on bone turnover: an evidence-based review..
Rev Recent Clin Trials. 8(1), 48-60.
(2013).
(2013). Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass..
Bone. 50(5), 1130-4.
(2012). Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011)..
Clin Infect Dis. 55(10), 1338-51.
(2012). High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density..
Horm Metab Res. 44(12), 909-13.
(2012). Reduced bone mineral density in patients with haemophilia A and B in Northern Greece..
Thromb Haemost. 107(3), 545-51.
(2012). Statins, bone formation and osteoporosis: hope or hype?.
Hormones (Athens). 11(2), 126-39.
(2012). Breast cancer and bone mineral density: the Marburg Breast Cancer and Osteoporosis Trial (MABOT II)..
Climacteric. 14(3), 352-61.
(2011). Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge..
Curr Opin Endocrinol Diabetes Obes. 18(6), 383-8.
(2011). Acute effects of recombinant human TSH on bone markers in differentiated thyroid cancer..
Hell J Nucl Med. 13(3), 208-12.
(2010). Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease..
J Bone Miner Metab. 28(6), 706-12.
(2010). The supratrochlear foramen of the humerus and its relation to the medullary canal: a potential surgical application..
Med Sci Monit. 16(4), BR119-123.
(2010).